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The extent of H/D exchange of the protein calmodulin in solution was monitored by mass
spectrometry following electrospray ionization (ESI) of the protein. In the absence of Ca21,
approximately 115 protons are exchanged for deuteriums after 60 min. As the calmodulin is
titrated with Ca21, the extent of exchange decreases significantly (i.e., by 24 protons),
indicating Ca21-induced folding of the protein to a tighter, less solvent-accessible form. The
extent of H/D exchange ceases to decrease when the amount of added Ca21 is sufficient to
convert greater than 80% of the calmodulin to a form bound by four calcium ions. Lysozyme,
a protein of similar molecular weight, does not show a significant decrease in the extent of
H/D exchange as it binds to Ca21, indicating that the changes in H/D exchange for calmodulin
reflect tertiary structural change that occur upon binding with Ca21. (J Am Soc Mass
Spectrom 1999, 10, 711–718) © 1999 American Society for Mass Spectrometry
Electrospray ionization (ESI) coupled with massspectrometry (MS) provides, in addition to mo-lecular weight, important information on the
structure of proteins [1]. For example, the extent of
charging and the resultant distribution of molecular
ions depend on conformation, solvent accessibility of
various sites, and effective pK values of the acidic and
basic functional groups on the side chains [2]. For many
proteins, there is a correlation between the maximum
number of charges and the number of basic amino-acid
residues [2–5]. For example, the maximum charge state
observed in the ESI mass spectrum of bovine ubiquitin
corresponds to the 13 basic residues that are available
for protonation.
The maximum of a charge-state distribution depends
on the conformation of the biomolecule in solution
[2–5]. Often when a protein is in a native conformation,
a narrow charge-state distribution centered at a high
mass-to-charge ratio (low charge states) pertains. Upon
denaturation, the protein conformation becomes more
open, undergoing a greater extent of charging and a
shift of the charge-state distribution to the lower mass-
to-charge (m/z) ratios.
Heat-induced conformational changes in proteins
also lead to alterations of charge-state distributions [6–8].
Increasing the temperature of the ESI interface induces
denaturation of proteins, leading to a shift in the charge
distribution to higher charge states (lower m/z).
Although charge-state distributions give some infor-
mation on three-dimensional structure, a more detailed
view can be achieved by hydrogen/deuterium (H/D)
exchange experiments, which can be monitored by
ESI-MS [2, 9–13]. Proteins with open structures have
amide hydrogens that are more accessible to the solvent
(D2O), and their exchange will proceed at higher rates
and to a greater extent. Native, tightly folded proteins
have fewer accessible amide hydrogens, leading to a
lower uptake of deuterium.
NMR has been the “gold standard” for measuring
hydrogen/deuterium exchange of proteins and identi-
fying intermediates in protein folding [14–17]. NMR
monitors the average exchange at individual sites over
the distribution of protein molecules, permitting inter-
pretation of the measured proton occupancies in the 3D
structure. Information on different populations of pro-
tein molecules, however, cannot be readily obtained by
NMR methods. Approximate molecular-weight limits
for H/D exchange by NMR are: 15 kDa (routine), 15–30
kDa (more difficult but feasible), and 30–50 kDa (pos-
sible in selected cases). The main limitation for large
proteins is establishing sequence-specific NMR reso-
nance assignments. Without assignments, an amide
exchange can still be monitored, but without site-
specificity. NMR is nondestructive, and the sample can
be fully recovered. The measurements are made for
molecules in the solution state; thus, there is no concern
about perturbing solution equilibria as there may be
when samples are taken from solution into the gas
phase, as is required by ESI-MS.
For H/D exchange, MS has advantages over NMR
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with respect to the sensitivity and molecular-weight
considerations. For the H/D exchange experiments by
NMR, 0.5 mL of a 0.5–1.5 mM solution is necessary,
whereas MS can be used in the micromolar concentra-
tion range although a number of solutions must be
prepared if kinetics are to be measured or titrations
conducted. MS can work with higher mass protein than
can NMR, and analyses are rapid. Although MS can
measure the most rapidly exchanging amide hydrogens
and NMR typically cannot, the simplicity of the data
interpretation for H/D exchange measurements is ap-
proximately the same for both NMR and MS.
H/D exchange and ESI/MS cannot directly provide
information on the location of hindered or exposed
amide hydrogens, but digestion of a labeled protein in
its folded state and further investigation of the peptide
fragments by ESI-MS can identify sites of slow and
rapid exchange [18–20]. This procedure coupled with
tandem mass spectrometry of the labeled peptide seg-
ments may ultimately allow the accurate location of
exchangeable sites. Despite its advantages, the use of
MS for H/D exchange is in its infancy, and more efforts
are required to validate its accuracy.
We chose the protein calmodulin to evaluate the
capability of ESI and MS to follow an interaction in
which metal–ion binding causes changes in the confor-
mation of the protein. The calcium ion can be viewed as
a messenger, and upon Ca21 binding, calmodulin binds
to target enzymes and related small molecules. Exam-
ples are the interactions of Ca21-loaded calmodulin
with small hydrophobic drugs [21], naturally occurring
peptides [22], and some enzymes [23]. The upshot of
these many studies is that calcium binding to calmod-
ulin is cooperative with respect to its two globular
domains and promotes a conformational change that
exposes a hydrophobic surface that is necessary for
binding to target enzymes. The affinity of the calcium-
loaded calmodulin to the targets can be seven orders of
magnitude greater than that of the apocalmodulin.
X-ray crystallographic studies of Ca21 binding pro-
teins show that they possess a common helix–loop–
helix (EF-hand) structural domain in their metal-bind-
ing sites. Although the X-ray structure of CaM-4Ca
(where CaM is calmodulin) has been determined, there
is no crystallographic determination of the apo-CaM
because suitable apocalmodulin crystals have not yet
been prepared. Nevertheless, NMR [24–27] was used to
obtain solution structures, and they suggest that each
domain of CaM-4Ca in solution has a greater surface
area, less flexibility, and a greater average separation
relative to apo-CaM.
The lack of direct X-ray crystallography data and the
success of our previous investigation of calmodulin, in
which we demonstrated the capability of ESI to detect
binding of Ca21-bound calmodulin to hydrophobic
peptides [28], have motivated us to examine the effect
of Ca21 binding on the folding of calmodulin by mass
spectrometry. Additional incentive comes from the re-
alization that the use of NMR to monitor H/D exchange
of the calcium-induced folding of calmodulin has not
been reported to our knowledge.
A final incentive is that we wish to develop an
alternate approach using ESI-MS to study peptide–
ligand interactions such as the binding of Ca21 to CaM
and the induced conformational changes in the protein.
Moreover, some controversy has arisen over the struc-
ture adopted by CaM-4Ca as determined by X-ray
diffraction [29–31], small-angle X-ray scattering [32, 33],
NMR [34–39], gel-permeation chromatography [40–
42], and lifetime-resolved fluorescence resonance en-
ergy transfer [43] studies.
Experimental
Materials
Porcine calmodulin MW 16792 Da was obtained from
Ocean Biologics Co. (Edmonds, WA), and hen egg
lysozyme was obtained from Sigma (St. Louis, MO).
ESI-Mass Spectrometry
ESI mass spectra were recorded by using a prototype
VG ZAB-T four-sector tandem mass spectrometer [44]
equipped with a VG electrospray source (Micromass,
Manchester, UK). A Harvard Model 22 syringe pump
(Harvard Apparatus, South Natick, MA) was used to
infuse a solution of 90/9/1 water/methanol/formic
acid to the spray needle at a rate of 10 mL/min. Samples
incubated for various time periods were introduced
into the solution via a 20-mL loop Rheodyne 7125 valve.
The spray needle was maintained at 8000 V, and the
counter electrode (pepper pot) potential was 5000 V.
The sampling cone, skimmer lens, skimmer, hexapole,
and ring electrode were 4200, 4160, 4160, 4150, and 4120
V, respectively. Nitrogen was used separately as both
bath and nebulizer gas with flow rates of 400 and 12 L/h,
respectively (the latter was the acceleration voltage).
The bath-gas temperature was maintained at 50 °C. The
mass spectrometer was calibrated from m/z 600 to 2600
by using a solution of CsI. All experiments made use of
only the first two sectors and were done with a mass
resolving power of 1300 (10% valley definition) and a
scan speed of 15 s/decade. Ten scans were signal
averaged and processed by using the VG Opus operat-
ing system realized on a DEC-alpha workstation. The
raw ESI spectra were transformed by using a maximum
entropy algorithm (MaxEnt) obtained from Micromass.
H/D Exchange Protocol
For H/D exchange of apocalmodulin, 1 mg of the
protein was dissolved in 400 mL of 20 mM ammonium
acetate buffer (pH 7, adjusted with ammonium hydrox-
ide), and a 10-mL aliquot was taken to determine the
extent of H/D exchange at a given time point in the rate
study. The exchange was initiated at room temperature
and pH 7 by mixing the 10-mL aliquot with 90 mL of
D2O (Cambridge Isotope Laboratories, Andover, MA)
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to give a protein concentration of 15 mM. After an
exchange period, which varied from 30 s to 24 h, the
exchange was quenched by adding 300 mL of ice-cold,
90/9/1 water/methanol/formic acid solution (pH 2.5).
Under these conditions of pH and temperature, the rate
constants for exchange are reduced by 4–5 orders of
magnitude [45]. A 20-mL aliquot with a final protein
concentration of 4 pmol/mL was loop-injected at
quench times that varied from 0 to 30 min for ESI-MS
analysis. The procedure was repeated to obtain the
time-dependent curve.
For the H/D exchange experiments of metal-loaded
calmodulin, 100 mL of 150-mM protein solution was
added to 100 mL of calcium acetate at various concen-
trations: 0.01, 0.02, 0.04, 0.09, 0.16, 0.25, 0.36, 0.49, 0.64,
0.81, and 1.0 mM (concentration of salt in exchange
media). A 20-mL aliquot was withdrawn to measure the
extent of H/D exchange at 60 min (a time when
exchange was relatively constant). The measurement of
H/D exchange for Ca21-bound CaM was performed at
room temperature and pH 7. Because the protein dena-
tures and releases calcium ions bound to it during the
quench event, it was the molecular weight of apocalm-
odulin that was recorded to give the number of deute-
riums exchanged. Exchange-rate curves for calmodulin
were obtained at 0.04 and 0.49 mM Ca21 concentrations.
For binding of CaM to magnesium, only one point at
0.49 mM Mg21 after 60 min of exchange was obtained.
For lysozyme, the H/D exchange kinetics curves were
obtained both in the absence of metal and in 0.49 mM
calcium acetate.
Results and Discussion
H/D Exchange Experiments
To examine the effect of Ca21 binding on calmodulin
folding, we submitted the apocalmodulin and holo-
calmodulin, which was formed in a titration with Ca21,
to H/D exchange and recorded the results with ESI-MS.
The deuterium-exchange experiment was in the “for-
ward” direction; that is, the protein at various points in
the titration was equilibrated in D2O as a function of
time. The difference in the molecular weights of deu-
terated and undeuterated calmodulin provides the av-
erage number of amide protons that exchanged with
deuterons (typical data are in Figure 1). Because the
difference is of the greatest interest, for every H/D
exchange experiment, a control experiment was con-
ducted in which samples were not incubated in D2O.
Apocalmodulin exchanged 125 amide (backbone)
protons for deuterons in 85% D2O/15% H2O, pH 7
during 24 h as determined by its increase in mass. The
extent of deuterium incorporation is 84% of the total
available amide hydrogens. Side chains containing
functional groups undergo facile H/D exchange and
are not counted because they are presumably rapidly
Figure 1. Typical ESI mass spectra of apocalmodulin after 0 and 60 min of H/D exchange. Note the
increase in mass, indicating exchange of 115 protons for deuterons.
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back-exchanged during the quench event that precedes
the MS measurement [45].
The effect of quench time on the number of ex-
changed backbone hydrogens was evaluated by vary-
ing the quench time from 0 to 30 min (for quench time
of 0 min, there is a 2-min delay from quench to
introduction into the mass spectrometer). An increase in
the back exchange of only two hydrogens (error is 61
hydrogen) occurred when the quenched solution was
held for 30 min instead of conducting the analysis
immediately. This observation proves that back ex-
change of functional groups on side chains was essen-
tially complete and that back exchange of amide deu-
teriums was not significant during the time between
quench and analysis [45].
To aid the interpretation of the H/D exchange re-
sults, we calculated, from the known Ca21 binding
constants, the binding fractions of the calcium-bound
species of calmodulin, CaM–xCa (x 5 024), as a func-
tion of total calcium concentration, CaT, at a total
calmodulin concentration, CaMT, of 15 mM. Owing to
the complexity of the equations involved, no analytic
solutions for calculating the binding fractions in terms
of the total calcium concentration are possible. There-
fore, we approached the problem indirectly by using
the concentration of free Ca, [Ca21], as an independent
parametric variable from which the binding fractions
and the corresponding total calcium concentration can
be calculated. Let the sequential additions of Ca21 to
calmodulin be represented
CaM 2 ~ x 2 1!Ca 1 Ca21
KX
º CaM2xCa
Kx 5 @CaM2xCa]/[CaM 2 ~ x 2 1!Ca] z [Ca
21]
where x 5 1–4 (1)
The Kx’s are the sequential equilibrium binding
constants: K1 5 1.3 3 10
5 M21, K2 5 3.7 3 10
5 M21,
K3 5 3.2 3 10
4 M21, and K4 5 3.2 3 10
4 M21 [25].
Total concentrations of calmodulin and calcium, CaT,
are given by:
CaMT 5 @CaM] 1 [CaM2Ca] 1 [CaM22Ca]
1 [CaM23Ca] 1 [CaM24Ca] (2)
CaT 5 @Ca] 1 [CaM2Ca] 1 2[CaM22Ca]
1 3 [CaM23Ca] 1 4[CaM24Ca] (3)
Figure 2. Fractional species calculation for Cax
21 (calmodulin) as a function of [Ca21]. The total
calmodulin concentration is 15 mM.
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By substituting the equilibrium equations to elimi-
nate explicit reference to calcium-bound species, we
obtain after algebraic manipulation:
CaMT 5 @CaM]*D (4)
D 5 1 1 K1@Ca
21# 1 K1K2@Ca
21]2 1 K1K2K3@Ca
21]3
1 K1K2K3K4@Ca
21]4 (5)
CaT 5 @Ca
21# 1 K1@Ca
21]CaMT$1 1 K2@Ca
21#
1 K2K3@Ca
21]2 1 K2K3K4@Ca
21]3}/D (6)
We define the binding fractions for the calcium-
bound species of calmodulin as fx 5 [CaM 2 xCa]/
CaMT for x 5 0 – 4, which corresponds to the fraction
of the calmodulin population having x Ca21 bound.
Upon elimination of the calcium-bound species, we
obtain:
f0 5 1/D (7)
f1 5 K1@Ca
21]/D (8)
f2 5 K1K2@Ca
21]2/D (9)
f3 5 K1K2K3@Ca
21]3/D (10)
f4 5 K1K2K3K4@Ca
21]4/D (11)
Thus, eqs 5–11 define the binding fractions, fx, and
the total calcium concentration, CaT, in terms of known
equilibrium binding constants, the known total calmod-
ulin concentration, CaMT, and the free concentration of
calcium, [Ca21]. We calculated a set of fx’s and CaT over
a range of [Ca21] from 10 nM to 0.10 M and plotted the
fx’s with respect to CaT for CaMT 5 15 mM (Figure 2)
from which we deduced the population of calcium-
bound calmodulin species for a given total calcium
concentration.
The extent of deuteration of the apo and the bound
calmodulin was measured in a time-dependent manner,
allowing us to construct a kinetic curve for the H/D
exchange (Figure 3). Exchange kinetics were studied for
apo and Ca21-loaded calmodulin at 0.04 and 0.49 mM
Ca21 concentrations. These two concentrations of cal-
cium acetate (0.04 and 0.49 mM) were chosen because,
according to the distribution of calcium-bound species,
the dominant calmodulin forms at 0.04 and 0.49 mM
Ca21 are CaM-2Ca and CaM-4Ca, respectively.
The differences in the amount of deuterium incorpo-
ration between calcium-free and calcium-loaded cal-
modulin at 0.04 and 0.49 mM Ca21 after 60 min of
incubation in D2O are 11 and 24 protons, respectively.
After 4 h, the observed protein mass (and presumably
the exchange) had become relatively constant; there-
fore, we present only the early part of the time depen-
dency for exchange. When calmodulin interacts with
0.49 mM Ca21 mM, the rate of exchange at times less
than 60 min appears to be smaller than that when
[Ca21] is 0.04 mM, and the extent of exchange reaches a
plateau after 1 h (Figure 3). The deuterium incorpora-
tion for the calmodulin when [Ca21] 5 0.49 mM is
lower than when [Ca21] 5 0.04 mM and must result
from new protection of exchangeable amide hydrogens,
presumably because the calcium-loaded calmodulin
assumes a more compact structure.
We then titrated calmodulin by varying the Ca21
concentration from 0.01 mM to 1 mM and submitted the
solution at discrete titration points to H/D exchange for
a time at which the exchange was relatively constant
(i.e., 60 min). When the concentration of calcium was
low (e.g., 0.01 and 0.02 mM) and the apo form was the
dominant species, there were no detectable changes in
deuterium uptake (Figure 4). When the concentration of
Figure 3. Time dependence for the H/D exchange of calmodulin,
with and without added Ca21. The extent of H/D exchange at one
time and for one concentration of Mg21 is given as a reference. The
solid and dashed lines are the best fits as judged by eye.
Figure 4. Ca21 titration curve for the H/D exchange of calmod-
ulin. Note the break at approximately 0.25 mM added Ca21. The
concentration of calmodulin was 15 mM. The solid line is the best
fit as judged by eye.
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calcium became sufficiently large such that other Ca21-
bound forms of calmodulin began to form, a decrease in
deuterium incorporation occurred. At [Ca21] 5 0.25
mM, the amount of deuterium that was incorporated
reached a minimum (Figure 4). At this concentration,
the CaM-4Ca is at least 85% of all forms of Ca21-bound
calmodulin (compare Figures 2 and 4). Upon further
increases in the calcium concentration (up to 1 mM), the
extent of deuteration increased slowly, possibly owing
to repulsion between excessive positive charge on the
protein surface as nonspecific Ca21 binding takes place,
leading to a slight “reopening” of the structure (non-
specific binding can be seen with MS [28]).
We also used ESI to monitor H/D exchange experi-
ments designed to reveal the structural changes of
calmodulin triggered by binding to Mg21. The extent of
deuterium incorporation in 0.49 mM Mg21 changed
only slightly from that of the apocalmodulin and is
substantially greater than that in 0.49 mM Ca21 (Figure
3). The much smaller decrease of H/D exchange in the
presence of Mg21 compared to that in the presence of
Ca21 indicates a less folded structure for Mg21-bound
calmodulin. This smaller extent of folding of calmodu-
lin upon addition of Mg21 is consistent with the
changes in CD and fluorescence spectra of calmodulin
in the presence of Mg21 and the interpretation that
Figure 5. Ribbon structures of the apo (dark) and Ca21-ligated (light) calmodulins showing two of
the four Ca-binding sites (top right and left). Structure coordinates are from [42] and were taken from
the NCBI database (apo: 1CMF and Ca21-bound: 1CMG).
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magnesium primarily binds to N-terminal domain of
calmodulin [46–48].
H/D Exchange of Lysozyme
To verify that the differences in H/D exchange are due
to differences in protein higher order structure and not
to changes in solution environment (e.g., changes in
ionic strength as Ca21 is added), we carried out control
experiments with lysozyme. Lysozyme (14 kDa) is
similar in size to calmodulin (17 kDa) and also binds
Ca21 and Mg21 ions. According to NMR [49] and X-ray
crystallography [50], the tertiary structures of apo and
metal-bound lysozymes are nearly superimpossible,
making them appropriate candidates for control exper-
iments.
Addition of 0.49 mM Ca21 to lysozyme led to the
formation of various metal-loaded species. The most
abundant metal-containing species formed upon ESI is
Lys-Ca, whereas Lys-2Ca and Lys-3Ca also form but are
less abundant.
We measured the extent of deuterium incorporation
in apolysozyme and Ca21-bound lysozyme in a time-
dependent manner. The differences in deuterium up-
take between apo and Ca21-bound lysozyme are very
small and remain nearly constant with time: differences
of six and eight protons exchanged after 60 and 240 min
of exchange, respectively. The exchange profiles as a
function of the time range that we investigated were not
significantly affected by binding of this protein to Ca21.
The relatively small differences in H/D exchange for
metal-free and metal-bound lysozyme are good evi-
dence that changes in H/D exchange of calmodulin
when titrated with Ca21 do result from changes in its
high order structure and not from some other unex-
pected effect.
Conclusion
The results of ESI-MS investigation of interaction of
calmodulin with Ca21 demonstrate that calmodulin
adopts a tighter, less solvent-accessible structure as the
protein binds with Ca21. The structural changes are
revealed in Figure 5, which contains an overlay of
approximately one half of the Ca21-ligated and the
apocalmodulin structures. The main effect of Ca21
binding is seen by comparing the apo (darker) struc-
ture) with the bound structure. In the apo structure, the
two Ca21 binding loops (on the upper right and left
portions of the figure) are located behind the plane of
the figure. They move forward upon ligation to Ca21,
causing the a-helices to become tighter and presumably
less accessible to water. Thus, the extent of H/D ex-
change decreases as the protein takes up Ca21. It is that
tighter structure that binds with proteins, peptides, and
other small molecules. Addition of Mg21 to calmodulin,
on the other hand, does not cause any significant
change in the tertiary structure of the protein.
If the binding constants for Ca21 and calmodulin
were not known, the end point in the titration may be a
convenient means of calculating an overall binding
constant. This may be a general outcome of a mass
spectrometry method that is applied to metal binding to
proteins.
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